Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Sny crawled date : 2022 - 07 - 28 save search
Sanofi Launches HBCU Diversity Partnership, Stays Strong in Q2 as Dupixent Th...
Published: 2022-07-28 (Crawled : 18:00) - biospace.com/
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 0.4%
H: 1.01%
C: 0.17%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: 0.0%
dupixent sanofi
Sanofi Launches HBCU Diversity Partnership, Stays Strong in Q2 as Dupixent Thrives
Published: 2022-07-28 (Crawled : 18:00) - biospace.com/
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 0.4%
H: 1.01%
C: 0.17%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: 0.0%
dupixent sanofi
Sanofi Stays Strong in Q2 as Dupixent thrives. Launches HBCU Diversity Partnership
Published: 2022-07-28 (Crawled : 16:00) - biospace.com/
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 0.4%
H: 1.01%
C: 0.17%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: 0.0%
partnership dupixent sanofi
Sanofi Stays Strong in Q2 as Dupixent thrives. Launches HBCU Diversity Partne...
Published: 2022-07-28 (Crawled : 15:20) - biospace.com/
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 0.4%
H: 1.01%
C: 0.17%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: 0.0%
dupixent sanofi
Alnylam Pharmaceuticals Reports Second Quarter 2022 Financial Results and Highlights Recent Period Activity
Published: 2022-07-28 (Crawled : 12:20) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: 0.0%
ALNY | $146.06 0.19% 0.18% 540K
|
Health Technology
|
| O: -3.5%
H: 6.04%
C: 4.76%
results
Prime Medicine Expands Leadership Team with Key Appointments to Support Continued Growth and Advancement of Prime Editing Technology and Portfolio
Published: 2022-07-28 (Crawled : 12:20) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: 0.0%
technology growth
Merck Announces Second-Quarter 2022 Financial Results
Published: 2022-07-28 (Crawled : 11:00) - biospace.com/
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: 0.0%
results
Innate Pharma to Participate in Upcoming Investor Conference - July 28, 2022
Published: 2022-07-28 (Crawled : 07:00) - biospace.com/
NVO | News | $128.64 2.7% -0.07% 3.7M
|
Health Technology
|
| O: -0.37%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: 0.0%
IPHA | $2.425 -7.02% 2.7K
|
Health Technology
|
| O: 4.94%
H: 3.7%
C: 1.35%
pharma conference
Press Release: Strong execution in Q2 drives full-year 2022 guidance upgrade and delivers rich R&D news flow in Immunology and Rare Disease
Published: 2022-07-28 (Crawled : 06:00) - globenewswire.com
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: 0.0%
rare disease immunology flow
Heparin Market Size to Grow by USD 2.29 billion, 37% of Market Growth to Originate from Europe - Technavio
Published: 2022-07-28 (Crawled : 01:00) - prnewswire.com
VTRS | News A | $11.36 0.98% 0.97% 4.7M
|
Health Technology
|
| O: -0.7%
H: 0.7%
C: -2.2%
BAX | $41.02 1.54% 0.0% 2.6M
|
Health Technology
|
| O: -7.56%
H: 1.47%
C: -3.64%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: 0.0%
europe growth market
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.